Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa

Microbiology

Volumn 147, Issue 10, 2001, Pages 2659-2669

  Feltman, H ^a   Schulert, G ^a   Khan, S ^a   Jain, M ^a   Peterson, L ^a   Hauser, A R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cystic fibrosis; ExoS; ExoT; ExoU; ExoY

Indexed keywords

ADENYLATE CYCLASE; CARRIER PROTEIN; EXOS PROTEIN; EXOT PROTEIN; EXOU PROTEIN; EXOY PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POPB PROTEIN; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD; CONTROLLED STUDY; CORRELATION FUNCTION; CYSTIC FIBROSIS; ENVIRONMENT; GENOTYPE; GRAM NEGATIVE INFECTION; HOSPITAL; HUMAN; HUMAN TISSUE; MARKER GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; SOUTHERN BLOTTING; SPUTUM; TRACHEA; URINE; WOUND;

BACTERIA (MICROORGANISMS); EXOS; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0034769748     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-147-10-2659     Document Type: Article

References (55)

1. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread
2. Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin
3. Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units
4. Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa
5. A simple and rapid method for the preparation of gram-negative bacterial genomic DNA
6. Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system
7. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells
8. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils
9. Nosocomial pneumonia in patients receiving continuous mechanical ventilation
10. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
11. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
12. The changing epidemiology of cystic fibrosis
13. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa
14. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S
15. Antimicrobial resistance in European isolates of Pseudomonas aeruginosa. European SENTRY participants
16. The exoenzyme S regulon of Pseudomonas aeruginosa
17. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin micro-filaments
18. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis
19. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages
20. Pseudomonas and related genera
21. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases
22. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries
23. Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells
24. PepA, a novel secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence
25. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras
26. Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers
27. Epidemiology of Pseudomonas aeruginosa in a burns hospital
28. Identification of Pseudomonas aeruginosa genes required for epithelial cell injury
29. Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein
30. Exogenous or endogenous reservoirs of nosocomial Pseudomonas aeruginosa and Staphylococcus aureus infections in a surgical intensive care unit
31. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
32. Epidemiological investigation of Pseudomonas aeruginosa nosocomial bacteremia isolates by PCR-based DNA fingerprinting analysis
33. Specific genomic fingerprints of phytopathogenic Xanthomonas and Pseudomonas pathovars and strains generated with repetitive sequences and PCR
34. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis
35. "Black holes" and bacterial pathogenicity: A large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli
36. National Nosocomial Infections Surveillance report, data summary from October 1986-April 1996, issued May 1996
37. Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells
38. Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S
39. Pseudomonadaceae
40. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?
41. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins
42. Nosocomial respiratory infections
43. Epidemiology of chronic Pseudomonas aeruginosa infection in cystic fibrosis
44. Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water
45. Analysis of Pseudomonas aeruginosa clinical isolates for possible variations within the virulence genes exotoxin A and exoenzyme S
46. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
47. Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells
48. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes
49. ADP-ribosylation of oncogenic Ras proteins by Pseudomonas aeruginosa exoenzyme S in vivo
50. Acetylornithinase of Escherichia coli partial purification and some properties
51. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites
52. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa
53. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III secretion pathway
54. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system